Relationship between uric acid levels and diagnostic and prognostic outcomes in acute heart failure

Open Biomarkers Journal

Volumn 5, Issue 1, 2012, Pages 9-15

  Henry Okafor, Queen ^a   Collins, Sean P ^b   Jenkins, Cathy A ^a   Miller, Karen F ^a   Maron, David J ^a   Naftilan, Allen J ^a   Weintraub, Neal ^b   Fermann, Gregory J ^b   Mcpherson, John ^a   Menon, Santosh ^c   Sawyer, Douglas B ^a   Storrow, Alan B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHRIST HOSPITAL   (United States)

Author keywords

Acute heart failure; B type natriuretic peptide; Prognostic outcomes; Uric acid

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; URIC ACID;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EMERGENCY PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; URIC ACID BLOOD LEVEL;

EID: 84865063315     PISSN: None     EISSN: 18753183     Source Type: Journal    
DOI: 10.2174/1875318301205010009     Document Type: Article

References (28)

1. Weintraub WS, Cole J, Tooley JF. Cost and cost-effectiveness studies in heart failure research. Am Heart J 2002; 143(4): 565-76.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 29;117(4):e25-146.
3. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115(5): e69-171.
4. Neily JB, Toto KH, Gardner EB, et al. Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. Am Heart J 2002;143(1): 29-33.
5. Rame JE, Sheffield MA, Dries DL, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 2001; 142(4): 714-9.
6. Collins SP, Peacock WF, Lindsell CJ, et al. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med 2009; 53(6): 748-57.
7. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347(3):161-7.
8. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 2004; 148(5): 895-902.
9. Maisel AS, Clopton P, Krishnaswamy P, et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 2004; 147(6): 1078-84.
10. Wu AH, Harrison A, Maisel AS. Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing. Eur J Heart Fail 2004; 6(3): 309-12.
11. Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44(6): 1328-33.
12. Daniels LB, Bhalla V, Clopton P, et al. B-type natriuretic peptide (BNP) levels and ethnic disparities in perceived severity of heart failure: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study of BNP levels and emergency department decision making in patients presenting with shortness of breath. J Card Fail 2006;12(4): 281-5.
13. Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 2009; 11(5): 444-52.
14. Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007; 17(6): 409-14.
15. Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27(10): 1174-81.
16. Doehner W, von Haehling S, Anker SD. Uric acid as a prognostic marker in acute heart failure--new expectations from an old molecule. Eur J Heart Fail 2007; 9(5): 437-9.
17. Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007; 9(5): 518-24.
18. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98(21): 2282-9.
19. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88(1): 107-15.
20. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285(26):1441-6.
21. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, editor. Vienna, Austria 2010. Available from http://www.R-project.org.
22. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP 2009
23. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53(4): 766-72.
24. Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010; 56(3): 486-95.
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3): 837-45.
26. Thanassoulis G, Brophy JM, Richard H, Pilote L. Gout, Allopurinol Use, and Heart Failure Outcomes. Arch Intern Med 2010; 170(15): 1358-64.
27. Anker SD, Rauchhaus M. Heart failure as a metabolic problem. Eur J Heart Fail. 1999; 1(2): 127-31.
28. Alimonda AL, Nunez J, Nunez E, et al. Hyperuricemia in acute heart failure. More than a simple spectator? Eur J Intern Med 2009; 20(1): 74-9.